Literature DB >> 21128281

Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients.

Ramprasath Venkatachalam1, Eugène T P Verwiel, Eveline J Kamping, Eveline Hoenselaar, Heike Görgens, Hans K Schackert, J Han J M van Krieken, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge, Ad Geurts van Kessel, Roland P Kuiper.   

Abstract

In the majority of colorectal cancers (CRCs) under clinical suspicion for a hereditary cause, the disease-causing genetic factors are still to be discovered. To identify such genetic factors we stringently selected a discovery cohort of 41 CRC index patients with microsatellite-stable tumors. All patients were below 40 years of age at diagnosis and/or exhibited an overt family history. We employed genome-wide copy number profiling using high-resolution SNP arrays on germline DNA, which resulted in the identification of novel copy number variants (CNVs) in six patients (15%) encompassing, among others, the cadherin gene CDH18, the bone morphogenetic protein antagonist family gene GREM1, and the breakpoint cluster region gene BCR. In addition, two genomic deletions were encountered encompassing two microRNA genes, hsa-mir-491/KIAA1797 and hsa-mir-646/AK309218. None of these CNVs has previously been reported in relation to CRC predisposition in humans, nor were they encountered in large control cohorts (>1,600 unaffected individuals). Since several of these newly identified candidate genes may be functionally linked to CRC development, our results illustrate the potential of this approach for the identification of novel candidate genes involved in CRC predisposition.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21128281     DOI: 10.1002/ijc.25821

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Identification of germline genomic copy number variation in familial pancreatic cancer.

Authors:  Wigdan Al-Sukhni; Sarah Joe; Anath C Lionel; Nora Zwingerman; George Zogopoulos; Christian R Marshall; Ayelet Borgida; Spring Holter; Aaron Gropper; Sara Moore; Melissa Bondy; Alison P Klein; Gloria M Petersen; Kari G Rabe; Ann G Schwartz; Sapna Syngal; Stephen W Scherer; Steven Gallinger
Journal:  Hum Genet       Date:  2012-06-05       Impact factor: 4.132

2.  Genome-wide copy number analysis in pediatric glioblastoma multiforme.

Authors:  Laura Giunti; Marilena Pantaleo; Iacopo Sardi; Aldesia Provenzano; Alberto Magi; Stefania Cardellicchio; Francesca Castiglione; Lorenzo Tattini; Francesca Novara; Anna Maria Buccoliero; Maurizio de Martino; Lorenzo Genitori; Orsetta Zuffardi; Sabrina Giglio
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

3.  Identification of a novel GREM1 duplication in a patient with multiple colon polyps.

Authors:  Danielle B McKenna; Jeroen Van Den Akker; Alicia Y Zhou; Lauren Ryan; Annette Leon; Robert O'Connor; Payal D Shah; Anil K Rustgi; Bryson W Katona
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

4.  Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences.

Authors:  E Waanders; B Scheijen; M C J Jongmans; H Venselaar; S V van Reijmersdal; A H A van Dijk; A Pastorczak; R D A Weren; C E van der Schoot; M van de Vorst; E Sonneveld; N Hoogerbrugge; V H J van der Velden; B Gruhn; P M Hoogerbrugge; J J M van Dongen; A Geurts van Kessel; F N van Leeuwen; R P Kuiper
Journal:  Leukemia       Date:  2016-10-13       Impact factor: 11.528

5.  Candidate predisposing germline copy number variants in early onset colorectal cancer patients.

Authors:  A J Brea-Fernandez; C Fernandez-Rozadilla; M Alvarez-Barona; D Azuara; M M Ginesta; J Clofent; L de Castro; D Gonzalez; M Andreu; X Bessa; X Llor; R Xicola; R Jover; A Castells; S Castellvi-Bel; G Capella; A Carracedo; C Ruiz-Ponte
Journal:  Clin Transl Oncol       Date:  2016-11-25       Impact factor: 3.405

6.  ROBO1 deletion as a novel germline alteration in breast and colorectal cancer patients.

Authors:  Rolando A R Villacis; Francine B Abreu; Priscila M Miranda; Maria A C Domingues; Dirce M Carraro; Erika M M Santos; Victor P Andrade; Benedito M Rossi; Maria I Achatz; Silvia R Rogatto
Journal:  Tumour Biol       Date:  2015-10-01

Review 7.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

8.  Importance of Cadherins Methylation in Ovarian Cancer: a Next Generation Sequencing Approach.

Authors:  Marcela Chmelarova; Ivana Baranova; Ema Ruszova; Jan Laco; Katerina Hrochova; Eva Dvorakova; Vladimir Palicka
Journal:  Pathol Oncol Res       Date:  2018-10-27       Impact factor: 3.201

9.  Germline DNA copy number variation in familial and early-onset breast cancer.

Authors:  Ana Cv Krepischi; Maria Isabel W Achatz; Erika Mm Santos; Silvia S Costa; Bianca Cg Lisboa; Helena Brentani; Tiago M Santos; Amanda Gonçalves; Amanda F Nóbrega; Peter L Pearson; Angela M Vianna-Morgante; Dirce M Carraro; Ricardo R Brentani; Carla Rosenberg
Journal:  Breast Cancer Res       Date:  2012-02-07       Impact factor: 6.466

10.  Germline copy number variations associated with breast cancer susceptibility in a Japanese population.

Authors:  Yutaka Suehiro; Takae Okada; Naoya Shikamoto; Yibo Zhan; Kohei Sakai; Naoko Okayama; Mitsuaki Nishioka; Tomoko Furuya; Atsunori Oga; Shigeto Kawauchi; Noriko Maeda; Michiko Tamesa; Yukiko Nagashima; Shigeru Yamamoto; Masaaki Oka; Yuji Hinoda; Kohsuke Sasaki
Journal:  Tumour Biol       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.